Correction to: npj Systems Biology and Applications https://doi.org/10.1038/s41540-024-00394-w, published online 21 June 2024
In the Acknowledgements section of this article, the team at AstraZeneca is referred to as the Early Computational Oncology team at AstraZeneca but should have been the Early Data Science team at AstraZeneca. Additionally, the name of the Co-Author Jay Mettetal should have been listed as Jerome Mettetal. Also the Supplementary File has been replaced. The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Papp, O., Jordán, V., Hetey, S. et al. Author Correction: Network-driven cancer cell avatars for combination discovery and biomarker identification for DNA damage response inhibitors. npj Syst Biol Appl 10, 83 (2024). https://doi.org/10.1038/s41540-024-00416-7
Published:
DOI: https://doi.org/10.1038/s41540-024-00416-7
